Cirrhosis in a child with hypothalamic syndrome and central precocious puberty treated with cyproterone acetate

European Journal of Pediatrics

Volumn 158, Issue 5, 1999, Pages 367-370

  Garty, B Z ^a   Dinari, G ^a   Gellvan, A ^b   Kauli, R ^c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b Clalit Health Services   (Israel)

^c NONE

Author keywords

Cirrhosis; Cyproterone acetate; Hypothalamic syndrome; Precocious puberty

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYPROTERONE ACETATE; FOLLITROPIN; GAMMA GLUTAMYLTRANSFERASE; GONADORELIN DERIVATIVE; GROWTH HORMONE RELEASING FACTOR; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE;

ADOLESCENT; ARTICLE; CASE REPORT; HUMAN; HYPOTHALAMUS DISEASE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER INJURY; LIVER TOXICITY; MALE; MULTIPLE ORGAN FAILURE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; CHILD; CYPROTERONE ACETATE; FATAL OUTCOME; HEPATITIS, TOXIC; HUMANS; HYPOTHALAMIC DISEASES; LIVER CIRRHOSIS; MALE; MULTIPLE ORGAN FAILURE; PROGESTERONE CONGENERS; PUBERTY, PRECOCIOUS; SEPSIS; SYNDROME;

EID: 0032945545     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051093     Document Type: Article

References (27)

1. 1. Angeli A, Boccuzzi G, Bislocci D, Fonzo D, Frajria R, De Sanctis S, Ceresa F (1976) Effects of cyproterone acetate therapy on gonadotrophin release to synthetic luteinizing hormone-releasing hormone (LRH) in girls with idiopathic precocious puberty. J Clin Endocrinol Metab 42:551-560
2. 2. Blake JC, Sawgerr AM, Dooley JS, Scheuer PJ, McIntyre N (1990) Severe hepatitis caused by cyproterone acetate. Gut 31:556-557
3. 3. Blank MS, Farnsworth PB (1974) Idiopathic symptomatic hypernatremia in a 9-year-old boy: a clinical and physiological evaluation. J Pediatr 85:215-219
4. 4. Conley SB, Brocklebank JK, Taylor IT, Robson AM (1976) Recurrent hypernatremia: a proposed mechanism in a patient with absence of thirst and abnormal water excretion. J Pediatr 89:898-903
5. 5. Dossing M, Buch-Andersen P (1982) Drug-induced liver disease in Denmark: an analysis of 572 cases of hepatotoxicity reported to the Danish Board of Adverse Reaction to Drugs. Scand J Gastroenterol 17:205-211
6. 6. Dunger DB, Leonard JV, Wolff OH, et al (1980) Effect of naloxone in a previously undescribed hypothalamic syndrome. Lancet 1:1277-1281
7. 7. Editorial (1976) Cyproterone acetate. Lancet 1:1003
8. 8. Geubel AP, De Galoosy C, Alves N, Rabier J, Dive C (1991) Liver damage caused by therapeutic vitamin A administration: estimate of the dose-related toxicity in 91 cases. Gastroenterology 100:1701-1709
9. 9. Hayek A, Peake GT (1982) Hypothalamic adipsia without demonstrable structural lesion. Pediatrics 70:275-278
10. 10. Hirsch D, Bernheim J, Kovatz, Shenkman L (1994) Fatal fulminant hepatitis from cyproterone acetate. Isr J Med Sci 30:238-240
11. 11. Husband P, Snodgrass G (1970) McCune-Albright syndrome with endocrinological investigations. Am J Dis Child 119:164-167
12. 12. Kaiser E, Grunter HS (1987) Liver structure and function during longterm treatment with cyproterone acetate. Arch Gynecol 240:217-223
13. 13. Kauli R, Pertzelan A, Prager-Lewin R, Grunbaum M, Laron Z (1976) Cyproterone acetate in treatment of precocious puberty. Arch Dis Child 51:202-208
14. 14. Kauli R, Prager-Lewin R, Keret R, Laron Z (1977) The LH and FSH responses to LH-releasing hormone (LH-RH) in girls with true precocious puberty treated with cyproterone acetate. Eur J Pediatr 125:205-212
15. 15. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z (1997) Final height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 47:54-61
16. 16. Kato K, Fujimoto M, Hibi I, Siwa S, et al (1993) The long-term effect of cyproterone acetate on growth in girls with idiopathic precocious puberty. Eur J Pediatr 152:297-300
17. 17. Laue L, Comite F, Hench K, Loriaux L, Cutler GB, Pescovitz OH (1985) Precocious puberty associated with neurofibromatosis and optic gliomas. Am J Dis Child 139:1097-1100
18. 18. Lee WM (1995) Drug-induced hepatotoxicity. N Engl J Med 333:1118-1127
19. 19. Lee WM, Denton WT (1989) Chronic hepatitis and indolent cirrhosis due to methyldopa: the bottom of the iceberg? JSC Med Assoc 85:75-79
20. 20. Levesque H, Manchon ND, Moore N, Courtois H, Trivable C, Vinel JP, Hemet J, Bercoff E, Bourreille J (1989) Fulminant hepatitis due to cyproterone acetate. Lancet 1:215-216
21. 21. Meijers WH, Willems PHB, Sleijfer DTR, Mulder NH, Grand J (1986) Hepatocellular damage by cyproterone acetate. Eur J Cancer Clin Oncol 22:1121-1122
22. 22. Neumann F (1977) Pharmacology and potential use of cyproterone acetate. Horm Metab Res 9:1-13
23. 23. Newman M, Auerbach R, Feiner H, et al (1989) The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment: improvement in liver abnormalities after cessation of treatment. Arch Dermatol 125:1218-1224
24. 24. Parys BT, Hamid S, Thomson RGN (1991) Severe hepatocellular dysfunction following cyproterone acetate therapy. B J Urol 67:312-313
25. 25. Schaad V, Vesella F, Zuppinger K, Oetliker O (1979) Hypodipsia-hypernatremia syndrome. Helv Paediatr Acta 34:63-76
26. 26. Starceski PJ, Lee PA, Albright AL, Migeon CJ (1990) Hypothalamic hamartomas and sexual precocity. Am J Dis Child 144:225-228
27. 27. Watanabe S, Cui Y, Tanae A, Tanaka T, Fujimoto M, Matsuo Y, Tachibana K, Yamasaki S (1997) Follow-up study of children with precocious puberty treated with cyproterone acetate. Ad hoc Committee for CPA. J Epidemiol 7(3):173-178